Enfusion Stock Earnings Per Share
| ENFNDelisted Stock | USD 10.76 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Enfusion's long-term financial health and intrinsic value.
Enfusion |
Enfusion Company Earnings Per Share Analysis
Enfusion's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Enfusion Earnings Per Share | 0.03 X |
Most of Enfusion's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Enfusion is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
CompetitionAccording to the company disclosure, Enfusion has an Earnings Per Share of 0.03 times. This is 96.94% lower than that of the Software sector and significantly higher than that of the Information Technology industry. The earnings per share for all United States stocks is 99.04% higher than that of the company.
Enfusion Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Enfusion's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Enfusion could also be used in its relative valuation, which is a method of valuing Enfusion by comparing valuation metrics of similar companies.Enfusion is currently under evaluation in earnings per share category among its peers.
Enfusion Fundamentals
| Return On Equity | 0.0442 | |||
| Return On Asset | 0.0305 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 1.01 B | |||
| Shares Outstanding | 94.8 M | |||
| Shares Owned By Insiders | 4.73 % | |||
| Shares Owned By Institutions | 96.25 % | |||
| Number Of Shares Shorted | 1.3 M | |||
| Price To Earning | 0.11 X | |||
| Price To Book | 13.93 X | |||
| Price To Sales | 5.06 X | |||
| Revenue | 201.61 M | |||
| Gross Profit | 136.74 M | |||
| EBITDA | 6.16 M | |||
| Net Income | 3.92 M | |||
| Cash And Equivalents | 56.56 M | |||
| Cash Per Share | 0.84 X | |||
| Total Debt | 20.31 M | |||
| Current Ratio | 9.17 X | |||
| Book Value Per Share | 0.77 X | |||
| Cash Flow From Operations | 34.68 M | |||
| Short Ratio | 1.46 X | |||
| Earnings Per Share | 0.03 X | |||
| Price To Earnings To Growth | 2.35 X | |||
| Target Price | 11.25 | |||
| Number Of Employees | 1.14 K | |||
| Beta | 0.93 | |||
| Market Capitalization | 1.02 B | |||
| Total Asset | 143.26 M | |||
| Retained Earnings | (170.11 M) | |||
| Working Capital | 66.19 M | |||
| Net Asset | 143.26 M |
About Enfusion Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Enfusion's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Enfusion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Enfusion based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Enfusion Stock
If you are still planning to invest in Enfusion check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enfusion's history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |